Photo for representational purpose only. - File photo
New Delhi, March 27
The Indian Council of Medical Research (ICMR) today said it would back Prevall, the country’s first oral chemotherapy drug for treating acute lymphoblastic leukaemia, the most common type of blood cancer afflicting children. Doctors from Tata Memorial Hospital, Mumbai, and the Advanced Centre for Training Research and Education in Cancer collaborated with IDRS Labs, Bengaluru, and developed the oral suspension of 6-mercaptopurine in India.
The Tribune News Service brings you the latest news, analysis and insights from the region, India and around the world. Follow the Tribune News Service for a wide-ranging coverage of events as they unfold, with perspective and clarity.
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Violence erupts in US universities as protesters and counter-protesters clash over war in Gaza
15 people are injured during the UCLA confrontation
Hope Palestine's application for UN membership will be reconsidered, endorsed: India
The US vetoed a resolution in the UN Security Council on a P...
Delhi Police dismiss claims of bombs being found in some schools as baseless
On Wednesday, over 80 schools in Delhi-NCR had received bomb...
2 killed as boiler explodes at rubber factory in Ludhiana
The incident takes place in the factory located in an indust...
Police killed student outside Wisconsin school after reports of someone with a weapon, official says
Authorities had previously said an active shooter who never ...
